Literature DB >> 2823805

Presence of functional receptors for atrial natriuretic peptide in human pheochromocytoma.

H Shionoiri1, N Hirawa, I Takasaki, Y Ishikawa, K Minamisawa, E Miyajima, Y Kinoshita, K Shimoyama, M Shimonaka, M Ishido.   

Abstract

Pheochromocytoma, a catecholamine-secreting adrenomedullary tumor, has been shown to contain the functional receptor for human atrial natriuretic peptide(h-ANP). Release of catecholamines from tissue slices of pheochromocytoma was inhibited by h-ANP in a dose-dependent manner. Binding assays using 125I-ANP revealed a single class of high affinity binding sites for ANP. When covalently tagged with 125I-ANP and electrophoresed under non-reducing and reducing conditions, the receptor migrated as a 140-kDa band and a 70-kDa band, respectively, reflecting its disulfide-linked subunit structure. The presence of ANP receptor in pheochromocytoma was further demonstrated by immunohistochemistry; the tumor was positively stained with an antireceptor antiserum. The antiserum was also useful to establish the zona glomerulosa localization of ANP receptor in the normal human adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823805     DOI: 10.1016/0006-291x(87)91108-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Differential regional expression of three natriuretic peptide receptor genes within primate tissues.

Authors:  J N Wilcox; A Augustine; D V Goeddel; D G Lowe
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

Review 2.  Atrial natriuretic peptide in peripheral organs other than the heart.

Authors:  A M Vollmar
Journal:  Klin Wochenschr       Date:  1990-07-17

3.  Effect of atrial natriuretic factor (ANF) on nicotinic acetylcholine receptor channels in bovine chromaffin cells.

Authors:  J Bormann; G Flügge; E Fuchs
Journal:  Pflugers Arch       Date:  1989-05       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.